Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950134-07-025080
Filing Date
2007-12-07
Accepted
2007-12-07 16:40:23
Documents
7
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K v36099e10vkza.htm 10-K/A 780894
2 EXHIBIT 23.1 v36099exv23w1.htm EX-23.1 1381
3 EXHIBIT 31.1 v36099exv31w1.txt EX-31.1 3398
4 EXHIBIT 31.2 v36099exv31w2.txt EX-31.2 3435
5 EXHIBIT 32.1 v36099exv32w1.txt EX-32.1 1106
6 EXHIBIT 32.2 v36099exv32w2.txt EX-32.2 1138
7 GRAPHIC v36099v3609900.gif GRAPHIC 11198
  Complete submission text file 0000950134-07-025080.txt   808374
Mailing Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814
Business Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814 4256083008
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-33393 | Film No.: 071293050
SIC: 2834 Pharmaceutical Preparations